XML 17 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Product sales, net $ 45,774 $ 0 $ 52,109 $ 0
License fees and milestones 15,000 0 15,000 15,000
Total revenues 60,774 0 67,109 15,000
Operating expenses:        
Cost of product sales 433 0 494 0
Research and development 22,463 20,942 96,213 71,708
Sales, general and administrative 43,873 17,494 113,597 44,413
Total operating expenses 66,769 38,436 210,304 116,121
Loss from operations (5,995) (38,436) (143,195) (101,121)
Other (expense) income, net:        
Gain/(loss) on sale/disposal of assets 5 (9) 7 8
Deferred gain on real estate 183 853 1,941 2,560
Interest expense (7,337) 0 (12,104) 0
Investment income, net 2,019 705 3,915 2,122
Total other (expense) income (5,130) 1,549 (6,241) 4,690
Net loss $ (11,125) $ (36,887) $ (149,436) $ (96,431)
Net loss per common share:        
Basic and diluted $ (0.13) $ (0.43) $ (1.70) $ (1.11)
Shares used in the calculation of net loss per common share:        
Basic and diluted 88,325 86,784 87,894 86,659
Other comprehensive loss:        
Net loss $ (11,125) $ (36,887) $ (149,436) $ (96,431)
Net unrealized gains/(losses) on available-for-sale securities 179 (148) (216) 790
Comprehensive loss $ (10,946) $ (37,035) $ (149,652) $ (95,641)